Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates
Syringe reading mistakes affect every dose from a vial
Your doctor may need to temporarily adjust or pause your GLP-1 medication
Other injectable medications are being studied, but these three remain the most widely prescribed and proven choices today
A provider-led process usually includes: Completing an online health intake Reviewing eligibility and medical history Meeting with a licensed clinician through telehealth Completing labs if needed Choosing a medication plan if medically appropriate Receiving medication through a licensed U.S